LAROCHE RICHARD F JR 4
4 · NATIONAL HEALTHCARE CORP · Filed May 9, 2025
Insider Transaction Report
Form 4
LAROCHE RICHARD F JR
Director
Transactions
- Award
Option to Purchase Common Stock [2025 Grant]
2025-05-08+7,500→ 7,500 totalExercise: $94.66From: 2026-05-08Exp: 2030-05-07→ Common Stock (7,500 underlying)
Holdings
- 114.833
Common Stock (ROTH IRA)
- 7,500
Option to Purchase Common Stock [2022 Grant]
Exercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying) - 205,912
Common Stock (held in my name or my wife's name)
- 96,000(indirect: GP)
Common Stock - Fam. Partnership (LFLP)
- 7,500
Option to Purchase Common Stock [2024 Grant]
Exercise: $96.03From: 2025-05-09Exp: 2029-05-08→ Common Stock (7,500 underlying) - 30,000(indirect: GP)
Common Stock - Family LP (BFLP)
- 28,000
Common Stock - Fam. Partnership (LR Ent.)
- 7,500
Option to Purchase Common Stock [2021 Grant]
Exercise: $71.64From: 2022-05-06Exp: 2026-05-05→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2023 Grant]
Exercise: $55.75From: 2024-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 8, 2025. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).